Clinical trial
The Safety and Efficacy of Escitalopram in Pediatric Patients With Major…
NCT00107120 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00107120 |
|---|---|
| Title | The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder |
| Official title | A Double-blind Flexible Dose Study of Escitalopram in Pediatric Patients With Major Depressive Disorder |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Escitalopram, Placebo |
| Enrollment | 312 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2007 |
| First posted | Apr 6, 2005 |
| Last update posted | Apr 6, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: